Margin assessment after neoadjuvant chemotherapy in invasive lobular cancer.

Wagner, Jamie; Boughey, Judy C; Garrett, Betsy; Babiera, Gildy; Kuerer, Henry; Meric-Bernstam, Funda; Singletary, Eva; Hunt, Kelly K; Middleton, Lavinia P; Bedrosian, Isabelle

Wagner, Jamie; Boughey, Judy C; Garrett, Betsy; Babiera, Gildy; Kuerer, Henry; Meric-Bernstam, Funda; Singletary, Eva; Hunt, Kelly K; Middleton, Lavinia P; Bedrosian, Isabelle.

Affiliation

Wagner J; Department of Surgical Oncology, The University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA.

Am J Surg ; 198(3): 387-91, 2009 Sep.

Article in En | MEDLINE | ID: mdl-19362281

Subject(s)

Breast Neoplasms/drug therapy; Breast Neoplasms/surgery; Carcinoma, Lobular/drug therapy; Carcinoma, Lobular/surgery; Adult; Aged; Aged, 80 and over; Breast Neoplasms/pathology; Carcinoma, Lobular/pathology; Chemotherapy, Adjuvant; Chi-Square Distribution; Female; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm, Residual/drug therapy; Neoplasm, Residual/pathology; Neoplasm, Residual/surgery; Reoperation; Retrospective Studies; Treatment Outcome

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Carcinoma, Lobular Type of study: Observational_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Am J Surg Year: 2009 Document type: Article Affiliation country: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google